Compare WASH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WASH | PHAR |
|---|---|---|
| Founded | 1800 | 1988 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 1.2B |
| IPO Year | 1994 | 2020 |
| Metric | WASH | PHAR |
|---|---|---|
| Price | $31.49 | $12.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $30.25 | ★ $38.33 |
| AVG Volume (30 Days) | ★ 212.6K | 9.9K |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.22% | N/A |
| EPS Growth | ★ 266.26 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $229,048,000.00 | N/A |
| Revenue This Year | N/A | $10.04 |
| Revenue Next Year | $6.19 | $2.51 |
| P/E Ratio | ★ $48.04 | $3,041.22 |
| Revenue Growth | ★ 127.57 | N/A |
| 52 Week Low | $25.23 | $8.69 |
| 52 Week High | $37.08 | $21.34 |
| Indicator | WASH | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 31.32 |
| Support Level | $28.26 | $11.02 |
| Resistance Level | $31.48 | $17.79 |
| Average True Range (ATR) | 0.83 | 0.37 |
| MACD | 0.01 | -0.45 |
| Stochastic Oscillator | 40.64 | 21.08 |
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.